Cooper Companies Inc
Cooper Companies specializes in health care products, including soft contact lenses and women's health solutions.
Price history of Cooper Companies Inc
Price history of Cooper Companies Inc
Performance & Momentum
Cooper Companies Q1 Earnings Beat Amid Stock Dip
Cooper Companies (COO) reported strong Q1 2026 results, with non-GAAP EPS surpassing analyst estimates by 6.9% and sales rising 6.2% in Q4 2025. The company raised its annual guidance, driven by MyDay and MiSight products. Despite positive earnings and margin expansion, the stock declined, likely due to a challenging macroeconomic environment, including unexpected healthcare employment contraction weighing on investor confidence.
Strategic Analysis
Cooper Companies Inc • 2026
Cooper Companies is a U.S. medical device specialist focused on two attractive niches: vision care, through contact lenses, and fertility, via dedicated equipment and solutions. This positioning gives it a relatively defensive profile, supported by recurring, non-cyclical markets, with a brand and specialist expertise that create barriers to entry.
- Niche positioning in recurring, structurally attractive healthcare markets
- Exposure to two distinct growth drivers, vision and fertility
- Medical device business that is generally less sensitive to economic cycles than other sectors
- Sustained deterioration in the stock trend, indicating weakened market confidence
- Dependent on its ability to sustain innovation, distribution, and margins in a competitive environment
Momentum is negative and reflects an underlying trend that remains fragile, with persistent pressure on the stock across multiple time horizons. For investors, this suggests waiting for clearer signs of operational stabilization or an improvement in market perception before reconsidering the name as a performance driver.
Similar stocks to Cooper Companies Inc
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
